Evidence map›Paper›PMID 20466958›Full record

ArticleAmerican journal of public health2010

"Our reach is wide by any corporate standard": how the tobacco industry helped defeat the Clinton health plan and why it matters now.

Laura E Tesler, Ruth E Malone

Abstract readHistorical Article
In one paragraph

Article in American journal of public health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. The atlas network: a "strategic ally" of the tobacco industry.The International journal of health planning and management · 2017
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. "Below the Line": The tobacco industry and youth smoking.The Australasian medical journal · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura E TeslerDepartment of Social and Behavioral Sciences, School of Nursing, University of California, San Francisco, San Francisco, CA 94143-0612, USA.
Ruth E Malone

Funding

Postdoctoral training in tobacco controlR25CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2006 to 2015
$5.4M
The Tobacco Problem:Public Health Implications of Contested FramesR01CA120138 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALONE, RUTH E · 2006 to 2016
$3.0M
Postdoctoral training in tobacco controlT32CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2016 to 2020
$2.6M
NCI NIH HHS CA113710NCI NIH HHS CA120138NCI NIH HHS R01 CA120138NCI NIH HHS R25 CA113710NCI NIH HHS T32 CA113710
6 · The paper itself

Abstract

Contemporary health care reformers, like those who promoted the failed Clinton era plan, face opposition from multiple corporate interests. However, scant literature has examined how relationships between corporations and other stakeholders, such as think tanks and advocacy groups, shape health care reform debate. We show how the 2 biggest US tobacco companies, Philip Morris and RJ Reynolds, and their trade association coordinated in mobilizing ideologically diverse constituencies to help defeat the Clinton plan. Unwittingly perhaps, some reform supporters advanced the tobacco industry's public relations blitz, contributing to perceptions of public opposition to the plan. As the current reform debate unfolds, this case highlights the importance of funding transparency for interpreting the activities of think tanks, advocacy groups, and "grassroots" movements.

Indexed as

LobbyingHealth Care ReformHealth PolicyHistory, 20th CenturyHumansSocial MarketingTaxesTobacco IndustryUnited States

Identifiers

PMID20466958
PMCPMC2882403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.